Acelrx Pharmaceuticals Inc. Stock
We can see a decrease in the price for Acelrx Pharmaceuticals Inc.. Compared to yesterday it has lost -€0.058 (-2.200%).
Currently there is a rather positive sentiment for Acelrx Pharmaceuticals Inc. with 4 Buy predictions and 1 Sell predictions.
As a result the target price of €2.00 shows a positive potential of 28.411% compared to the current price of €1.56 for Acelrx Pharmaceuticals Inc..
For the coming years our community has positive and negative things to say abot the Acelrx Pharmaceuticals Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Currently there is a rather positive sentiment for Acelrx Pharmaceuticals Inc. with 4 Buy predictions and 1 Sell predictions.
As a result the target price of €2.00 shows a positive potential of 28.411% compared to the current price of €1.56 for Acelrx Pharmaceuticals Inc..
For the coming years our community has positive and negative things to say abot the Acelrx Pharmaceuticals Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Acelrx Pharmaceuticals Inc. in the next few years
Performance of Acelrx Pharmaceuticals Inc. vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Acelrx Pharmaceuticals Inc. | -2.200% | -9.342% | 52.996% | -4.827% | 65.445% | -7.292% | -46.459% |
| Atara Biotherapeutics Inc. | -0.800% | -1.752% | -18.317% | 14.523% | -9.205% | - | - |
| Otonomy Inc. | 3.510% | -5.811% | -18.042% | 23.311% | -16.967% | - | - |
| Sunesis Pharmaceuticals Inc. | -3.160% | 4.184% | 65.449% | -50.693% | 67.114% | -93.006% | -94.638% |
Comments
Sell Acelrx Pharmaceuticals Inc.
Other discussions about Acelrx Pharmaceuticals Inc. Stock
Trading Acelrx Pharmaceuticals Inc.
Trading Acelrx Pharmaceuticals Inc.
